Danish Pharmaceuticals & Biotech Leverage Leaders

Bavarian Nordic

Market Cap: DKK 16.1b

Develops, manufactures, and supplies life-saving vaccines.

ALK-Abelló

Market Cap: DKK 47.5b

An allergy solutions company, develops treatments for respiratory allergy, anaphylaxis, and food allergy and new disease areas in the European Union, the United Kingdom, Norway, Switzerland, the United States, Canada, Japan, China, and internationally.